zur Navigation zum Inhalt
Onkologie 21. Oktober 2010

Pharmacoeconomy in cancer therapy

Undoubtedly, enormous progress has been made in the field of oncology in general and in the development of new systemic therapies in particular. Due to competing societal needs, (pharmaco-) economic deliberations for the most equitable allocation of the always limited financial resources have to be used. It is this author's conviction that no other segment of society is better qualified to address the question what counts as a benefit in cancer treatment and how much costs are justified to be taken over by the society as the global payer to cover that progress than the oncologists themselves, provided they are willing to take over this task on an educated, rational and transparent basis.

Zu diesem Thema wurden noch keine Kommentare abgegeben.

Mehr zum Thema

<< Seite 1 >>

Medizin heute

Aktuelle Printausgaben